Discover a new way to find and share stories you'll loveā€¦ Learn about Reading Desk

Post Profile

Podcast Interview on Drug Discovery

Here's an interview that I did recently with Paul Howard of the Manhattan Institute on the results of that immunotherapy leukemia trial (and on some broader topics around the current state of drug discovery). Anyone who would like to pitch a blockbuster syndicated radio show with me on structure-activity relationships and preclinical drug development, have your people call my people.
read more


Drug Shows Promise for T315I-Mutated Chronic Myeloid Leukemia

Health : Newswise Medical News (5 years ago)

Results from a phase II clinical trial indicate a novel drug may provide a treatment option for chronic myeloid leukemia (CML) patients who do not respond to current therapies, researchers from The University of Texas M. D. Anderson... Read Post

Powerful Drug Candidate For Leukemia A Result Of Unconventional Hunt For New Cancer Targets

Health : Medical News Today (3 years ago)

Scientists at Cold Spring Harbor Laboratory (CSHL) and five other institutions have used an unconventional approach to cancer drug discovery to identify a new potential treatment for acute myeloid leukemia (AML). As reported in Natu... Read Post

Manhattan Institute Scholars Propose New Compensation Program For Injured Drug Users

Health : Medical News Today (6 years ago)

In a new report released, "In the Wake of Wyeth v. Levine: Making the Case for FDA Preemption and Administrative Compensation," Manhattan Institute scholars Paul Howard and James Copland respond to the recent Supreme Court Case ruli... Read Post

Copyright © 2011 Regator, LLC